Suitable for small batches in pharma, food and cosmetics industries
Generare has secured €20m in Series A funding to scale its evolution‑based molecular platform, which generated more novel high-quality small molecules in 2025 than all...
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.